Allurion Technologies, Inc. Common Stock (ALUR)

Keep an eye on the top gainers and losers in Wednesday's session, as they reflect the most notable price movements.

Curious about what's happening in today's session? Check out the latest stock movements and price changes.

Let's delve into the US markets on Wednesday and uncover the stocks that are experiencing notable gaps in today's session. Below, you'll find the gap up and gap down stocks.

Curious about the most active stocks in today's session? Get a glimpse into the stocks that are generating the highest trading volume and capturing market attention.

Wondering how the US markets performed in the middle of the day on Friday? Discover the movers and shakers of today's session in our comprehensive analysis.

In today's session, there are notable price gaps in the US markets on Friday. Take a closer look at the stocks that are gap up and gap down.

While the other companies are testing weight-loss drugs, Allurion has a different approach to obesity.

Allurion Technologies (NYSEALUR) shares are moving higher Friday potentially after after the company announced plans to conduct a clinical study evaluating the combination of its Allurion Program with GLP-1 agonists on Thursday.

U.S. stock futures fell on Friday following a 25 basis point rate hike by the Bank of Japan. Futures of all four indices declined.